Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.0K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.3K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

508
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
508
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.1K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

896
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
896
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

464
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
464

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Invasive mycoses in France: what are the trends?]

La Revue du praticien·2026
Same author

[Candidemia: the most frequent invasive fungal infection in France].

La Revue du praticien·2026
Same author

Antifungal exposure in <i>Scedosporium</i> septic arthritis: synovial penetration of voriconazole and terbinafine and plasma concentrations of olorofim.

Antimicrobial agents and chemotherapy·2026
Same author

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

The Journal of experimental medicine·2026
Same author

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same author

Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a prospective observational cohort study.

The Journal of infection·2026

Related Experiment Video

Updated: Jan 27, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.6K

Disease Entities in Mucormycosis.

Alexandra Serris1, François Danion2, Fanny Lanternier3,4

  • 1Université Paris Descartes, Centre d'Infectiologie Necker Pasteur, IHU Imagine, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), 75015 Paris, France. alexandra.serris@gmail.com.

Journal of Fungi (Basel, Switzerland)
|March 17, 2019
PubMed
Summary

Mucormycosis is a severe fungal infection affecting immunocompromised individuals. Early detection via DNA testing and prompt treatment including antifungals, disease correction, and surgery are crucial for patient survival.

Keywords:
MucoralesMucormycosishealth-carepulmonary mucormycosisrhino-orbito-cerebral mucormycosis

More Related Videos

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.3K
Author Spotlight: High-Throughput In Vivo Leaf Inoculation for Accelerating Disease Resistance Screening in Poplar Hybrid Breeding
09:31

Author Spotlight: High-Throughput In Vivo Leaf Inoculation for Accelerating Disease Resistance Screening in Poplar Hybrid Breeding

Published on: September 20, 2024

1.2K

Related Experiment Videos

Last Updated: Jan 27, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.6K
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.3K
Author Spotlight: High-Throughput In Vivo Leaf Inoculation for Accelerating Disease Resistance Screening in Poplar Hybrid Breeding
09:31

Author Spotlight: High-Throughput In Vivo Leaf Inoculation for Accelerating Disease Resistance Screening in Poplar Hybrid Breeding

Published on: September 20, 2024

1.2K

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Mucormycosis, caused by Mucorales fungi, is a life-threatening infection.
  • Primarily affects immunocompromised patients with conditions like hematological malignancy, transplantation, or diabetes mellitus.
  • Diverse clinical presentations include rhino-orbito-cerebral, pulmonary, cutaneous, gastrointestinal, and disseminated forms.

Purpose of the Study:

  • To review the epidemiology, clinical manifestations, and diagnostic approaches to mucormycosis.
  • To highlight the association between specific mucormycosis forms and underlying diseases.
  • To emphasize the importance of early diagnosis and multimodal treatment strategies.

Main Methods:

  • Literature review of mucormycosis presentations and diagnostic tools.
  • Analysis of clinical and radiological findings, including the reversed halo sign.
  • Evaluation of novel diagnostic methods like circulating Mucorales DNA detection.

Main Results:

  • Pulmonary mucormycosis is more common in hematological malignancy, while rhino-orbito-cerebral is linked to diabetes.
  • Clinical symptoms and CT scans are often non-specific, except for the reversed halo sign in pulmonary cases.
  • Circulating Mucorales DNA detection shows promise for earlier diagnosis and treatment initiation.

Conclusions:

  • Mucormycosis requires a high index of suspicion in at-risk populations.
  • Early diagnosis, potentially aided by DNA detection, is critical.
  • Treatment should be comprehensive, involving antifungal therapy, underlying disease management, and surgical intervention when necessary.